This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Western University of Health Sciences. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Maria Polikandritou Lambros: Innovator in Cancer Therapy
Introduction
Maria Polikandritou Lambros is a prominent inventor based in Pomona, CA (US). She has made significant contributions to the field of cancer therapy through her innovative research and development of targeted liposomes. Her work focuses on improving the delivery of therapeutic and diagnostic agents for the treatment of hyperproliferative diseases.
Latest Patents
Maria holds a patent for her invention titled "Targeted liposomes in cancer therapy." This invention provides pharmaceutical compositions that contain a vehicle designed for the targeted delivery of therapeutic and diagnostic agents. The targeting component of the vehicle is a cystine molecule that is coupled to the cargo component, which can either be a therapeutic or diagnostic agent or a nanoparticle composition containing the therapeutic agent or diagnostic. The invention also outlines methods for treating hyperproliferative disorders by specifically targeting hyperproliferative disease cells for the delivery of these agents. Maria has 1 patent to her name.
Career Highlights
Maria Polikandritou Lambros is affiliated with the Western University of Health Sciences, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer treatment methodologies.
Collaborations
Maria collaborates with esteemed colleagues, including Ying Huang and Hari Chandana Mulamalla, to advance her research and explore new avenues in cancer therapy.
Conclusion
Maria Polikandritou Lambros is a trailblazer in the field of cancer therapy, with her innovative patent on targeted liposomes showcasing her commitment to improving treatment options for patients. Her contributions are paving the way for future advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
